(Q33909615)

29 July 2017

1 reference

title

Pharmacological interventions for acute spinal cord injury (English)

1 reference

29 July 2017

M B Bracken

1

1 reference

29 July 2017

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

1 reference

29 July 2017

CD001046

1 reference

29 July 2017

2

1 reference

Pharmacological treatment of acute spinal cord injury: current status and future prospects

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

The perioperative use of corticosteroids and bupivacaine in the management of lumbar disc disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

High-dose methylprednisolone prevents extensive sick leave after whiplash injury. A prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Methylprednisolone and acute spinal cord injury: an update of the randomized evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

The neuroprotective pharmacology of methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Efficacy of Methylprednisolone in Acute Spinal Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

The effect of methylprednisolone, naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS 2. National Acute Spinal Cord Injury Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

[Medical treatment of spinal cord injury in the acute stage]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Pharmacological therapy of spinal cord injury during the acute phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Incidence of acute traumatic hospitalized spinal cord injury in the United States, 1970-1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Experimental Treatments of Acute Spinal Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Variance imputation for overviews of clinical trials with continuous response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

Risk of avascular necrosis following short term megadose methylprednisolone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001046

10.1002/14651858.CD001046

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10796741